Skip to main content
. 2010 Oct 7;1(12):796–809. doi: 10.1021/cn100073x

Table 1. Effect of MLA Analogs 26 at α4β2, α3β4, and α7 nAChRs.

α4β2
α3β4
α7
analog IC50 (μM)a (95% CI)b Imaxc IC50 (μM)a (95% CI)b Imaxc IC50 (μM)a (95% CI)b Imaxc
2d 7.15 (4.1−12.3) 0.39 (0.24−0.54) 16.0 (6.0−42.4) 0.89 (0.77−1.00) 11.2 (5.5−22.8) 0.92 (0.34−1.5)
3 21.1 (13.7−32.3) 0.24 (0.24−0.27) 7.9(5.5−11.4) 0.80 (0.69−0.92) 26.6 (18−37.6) 0.58 (0.55−0.59)
4 4.66 (2.3−9.2) 0.52 (0.28−0.71) 2.3 (0.9−6.2) 0.26 (0.16−0.36) 20.7 (7.0−61.4) 1.06 (0.79−1.32)
5e 11.6 (5.2−25.9) 0.58 (0.43−0.72) 14.3 (2.5−24.8) 0.53 (0.46−0.61) 23.5 (12.2−45.1) 0.53 (0.39−0.68)
5f 53.2 (18.8−150.6) 1.06 (0.88−1.24)        
6 10.9 (2.4−49.8) 0.70 (0.58−0.82)        
a

The concentration of the antagonist that inhibit 50% of ACh response (EC50; the concentration that activates 50% of maximum response) at the nAChR specified. The EC50 concentrations for ACh used were 100 (α4β2), 300, (α3β4), and 300 μM (α7).

b

95% Confidence Intervals (CI); data obtained from 3 to 12 oocytes.

c

Imax is the maximum current produced by ACh alone or ACh in the presence of antagonist (30 μM) at a specified nAChR.

d

Data taken from ref (14).

e

Data for bicyclic alcohol 5 with a 3 min preincubation.

f

Data for bicyclic alcohol 5 with no preincubation.